Catalent Gains After Report Sale to Novo Holdings Could Close Soon
Novo Nordisk's Wegovy Sales Drop Is Temporary; Forecasts Still on Track -- Market Talk
10 Health Care Stocks Whale Activity In Today's Session
Evotec And Novo Nordisk Launch First Projects For LAB EN2 Accelerator, Focusing On Cardiometabolic Diseases
Eli Lilly and Co (LLY.US) seeks to expand the indications for its weight loss medication and will conduct trials to treat addictive behaviors.
Eli Lilly and Co will test a weight loss drug for treating addiction in 2025.
BofA Restarts Coverage of 11 Large-cap Biopharmas
Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
Eikonizo Therapeutics Announces Investment by Novo Nordisk; Advancing Lead Candidate EKZ-102 Toward Clinical Development
Express News | Novo Nordisk Says Investment Aimed At Expanding Enzymes Output Used For The Production Of Insulin, GLP-1 Medicines
Express News | Novo Nordisk To Invest Additional 500M Reais To Expand Factory In Brazil
Novo Nordisk Just Got One Step Closer to Resolving Wegovy Supply Issue -- Barrons.com
PFE or NVO: Which Is the Better Value Stock Right Now?
Phase 2 Data From the Ongoing HIBISCUS Study Shows Promise That Investigational Etavopivat Could Reduce the Incidence of Vaso-occlusive Crises in People With Sickle Cell Disease
Catalent's Proposed Acquisition by Novo Holdings Wins European Commission Nod
Express News | EU Regulators Say Novo Holdings Secures Unconditional EU Antitrust Approval For $16.5B Catalent Deal
European Equities Traded in the US as American Depositary Tread Water in Friday Trading
US stocks move | Selling Czech factory, novavax (NVAX.US) rises over 12%.
As of the time of writing, the stock has risen over 12%, reported at $9.355.
Novo Nordisk Catalysts Could Drive Over 30% Upside to Shares -- Market Talk
Novo Nordisk (NVO) Stock Moves -0.14%: What You Should Know
How Much Did Americans Overspend On Weight Loss Medications in 2024? GoodRx Reveals